Arcutis Biotherapeutics

Arcutis Biotherapeutics

ARQT· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +108.5% in FY2025

Todd Franklin Watanabe is the CEO of Arcutis Biotherapeutics and was paid $7.2M in FY2025 (Dec), up 96%.

Pay$100 in the stock at the end of FY21 → $140
CEO pay is from each Arcutis Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1Todd Franklin WatanabeFY2025
  2. 2L. Todd EdwardsFY2025
  3. 3Patrick E. BurnettFY2025
  4. 4Masaru Matsuda, J.D.FY2025
  5. 5David TopperFY2025
  6. 6Latha VairavanFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Arcutis Biotherapeutics paid its 6 named executives $19.3M in total in FY2025 (Dec). CEO Todd Franklin Watanabe was paid $7.2M of that.

Name
Todd Franklin WatanabePresident and Chief Executive Officer
L. Todd EdwardsChief Commercial Officer
Patrick E. Burnett
Masaru Matsuda, J.D.Chief Legal Officer
David TopperFormer Chief Financial OfficerNot disclosed
Latha VairavanChief Financial OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2025 (Dec) proxy of Arcutis Biotherapeutics names 17 peer companies for pay. Among Arcutis Biotherapeutics and these peers, CEO pay was 5th highest of 7 and total shareholder return was 5th highest of 7.

5th highest of 7in Arcutis Biotherapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$5.4M$12.9M

5th highest of 7in Arcutis Biotherapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$63$495

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Halley GilbertDirector · 5 yr on the boardIndependentAudit—Paid as an executive
  • Terrie CurranDirector · 5 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
  • Neha KrishnamohanDirector · 3 yr on the boardIndependentAudit—Paid as an executive
  • Amit MunshiDirector · 0 yr on the boardIndependentCompensation (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. Pay
    Arcutis Biotherapeutics CEO pay rose 96% to $7.2M. The stock rose 108% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Arcutis Biotherapeutics Division head pay rose 54% to $3.0M. The stock rose 108% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Pay for Patrick E. Burnett at Arcutis Biotherapeutics rose 20% to $3.0M. The stock rose 108% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Arcutis Biotherapeutics General counsel pay rose 22% to $2.1M. The stock rose 108% in FY2025 (Dec).
    DEF 14A
  5. Pay
    Arcutis Biotherapeutics Former CFO pay fell 63% to $1.9M. The stock rose 108% in FY2025 (Dec).
    DEF 14A
  6. Pay
    Arcutis Biotherapeutics Chief Medical Officer pay rose 51% to $2.5M. The stock rose 331% in FY2024 (Dec).
    DEF 14A
  7. Board
    Amit D. Munshi joined the board of Arcutis Biotherapeutics. Amit D. Munshi now sits on 3 public boards.
    3
  8. Pay
    Arcutis Biotherapeutics CEO pay fell 25% to $3.7M. The stock rose 331% in FY2024 (Dec).
    DEF 14A
  9. Pay
    Arcutis Biotherapeutics Division head pay rose 19% to $2.0M. The stock rose 331% in FY2024 (Dec).
    DEF 14A
  10. Pay
    Pay for Patrick E. Burnett at Arcutis Biotherapeutics rose 51% to $2.5M. The stock rose 331% in FY2024 (Dec).
    DEF 14A
  11. Pay
    Arcutis Biotherapeutics General counsel pay fell 69% to $1.6M. The stock fell 78% in FY2023 (Dec).
    DEF 14A
  12. Pay
    Arcutis Biotherapeutics CFO pay rose 103% to $2.1M. The stock rose 331% in FY2024 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 21, 2026FY2025
Annual report10-KFeb 25, 2026FY2025
Proxy statementDEF 14AApr 29, 2025FY2024
Annual report10-KFeb 25, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KFeb 27, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data